Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population

Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population‐based case–control study was conducted and 2,011 liver cancer...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 142; no. 8; pp. 1560 - 1567
Main Authors Liu, Xing, Baecker, Aileen, Wu, Ming, Zhou, Jin‐Yi, Yang, Jie, Han, Ren‐Qiang, Wang, Pei‐Hua, Jin, Zi‐Yi, Liu, Ai‐Min, Gu, Xiaoping, Zhang, Xiao‐Feng, Wang, Xu‐Shan, Su, Ming, Hu, Xu, Sun, Zheng, Li, Gang, Mu, Lina, He, Na, Li, Liming, Zhao, Jin‐Kou, Zhang, Zuo‐Feng
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 15.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population‐based case–control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum hepatitis B surface antigen (HBsAg) and anti‐HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semi‐Bayes (SB) method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratios (OR) for ever smoking were 1.62 (95% confidence interval [CI]: 1.33–1.96) among male and 0.82 (95% CI: 0.53–1.26) among female. Age at first cigarette, duration of smoking and pack‐years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg‐negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03–1.52) for HBsAg‐negative ever smokers, 7.66 (95% CI: 6.05–9.71) for HBsAg‐positive never smokers, and 15.68 (95% CI: 12.06–20.39) for HBsAg‐positive ever smokers. These different odds ratios indicated super‐additive (RERI: 7.77, 95% CI: 3.81–11.73) and super‐multiplicative interactions (ROR: 1.64, 95% CI: 1.17–2.30) between hepatitis B virus (HBV) infection and tobacco smoking. Most associations and interactions detected remained statistically significant after SB adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer. What's new? Tobacco smoking is a major risk factor for various cancer types, including liver cancer. Half of new liver cancer cases reported annually worldwide occur in China, where the prevalence of smoking and hepatitis B virus (HBV) infection are high. Here, associations between tobacco smoking and liver cancer and interactions between smoking and other risk factors were examined in a Chinese population. Significant interactions were detected between smoking and HBV infection. Analyses by gender indicated that associations between smoking and liver cancer existed primarily among men, who were more likely than women to have been ever smokers or current smokers.
AbstractList Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population-based case-control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum HBsAg and anti-HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semi-Bayes method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratio for ever smoking was 1.62 (95% CI: 1.33 – 1.96) among male and was 0.82 (95% CI: 0.53–1.26) among female. Age at first cigarette, duration of smoking and pack-years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg negative never-smokers, the adjusted OR was 1.25 (95% CI: 1.03–1.52) for HBsAg-negative ever smokers, was 7.66 (95% CI: 6.05–9.71) for HBsAg-positive never smokers, and was 15.68 (95% CI: 12.06–20.39) for HBsAg-positive ever smokers. These different odds indicated super-additive (RERI: 7.77, 95% CI: 3.81–11.73) and super-multiplicative interactions (ROR: 1.64, 95% CI: 1.17–2.30) between HBV infection and tobacco smoking. Most associations and interactions detected remained statistically significant after semi-Bayes adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer.
Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population‐based case–control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum hepatitis B surface antigen (HBsAg) and anti‐HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semi‐Bayes (SB) method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratios (OR) for ever smoking were 1.62 (95% confidence interval [CI]: 1.33–1.96) among male and 0.82 (95% CI: 0.53–1.26) among female. Age at first cigarette, duration of smoking and pack‐years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg‐negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03–1.52) for HBsAg‐negative ever smokers, 7.66 (95% CI: 6.05–9.71) for HBsAg‐positive never smokers, and 15.68 (95% CI: 12.06–20.39) for HBsAg‐positive ever smokers. These different odds ratios indicated super‐additive (RERI: 7.77, 95% CI: 3.81–11.73) and super‐multiplicative interactions (ROR: 1.64, 95% CI: 1.17–2.30) between hepatitis B virus (HBV) infection and tobacco smoking. Most associations and interactions detected remained statistically significant after SB adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer. What's new? Tobacco smoking is a major risk factor for various cancer types, including liver cancer. Half of new liver cancer cases reported annually worldwide occur in China, where the prevalence of smoking and hepatitis B virus (HBV) infection are high. Here, associations between tobacco smoking and liver cancer and interactions between smoking and other risk factors were examined in a Chinese population. Significant interactions were detected between smoking and HBV infection. Analyses by gender indicated that associations between smoking and liver cancer existed primarily among men, who were more likely than women to have been ever smokers or current smokers.
Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population-based case-control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum hepatitis B surface antigen (HBsAg) and anti-HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semi-Bayes (SB) method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratios (OR) for ever smoking were 1.62 (95% confidence interval [CI]: 1.33-1.96) among male and 0.82 (95% CI: 0.53-1.26) among female. Age at first cigarette, duration of smoking and pack-years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg-negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03-1.52) for HBsAg-negative ever smokers, 7.66 (95% CI: 6.05-9.71) for HBsAg-positive never smokers, and 15.68 (95% CI: 12.06-20.39) for HBsAg-positive ever smokers. These different odds ratios indicated super-additive (RERI: 7.77, 95% CI: 3.81-11.73) and super-multiplicative interactions (ROR: 1.64, 95% CI: 1.17-2.30) between hepatitis B virus (HBV) infection and tobacco smoking. Most associations and interactions detected remained statistically significant after SB adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer.Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population-based case-control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum hepatitis B surface antigen (HBsAg) and anti-HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semi-Bayes (SB) method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratios (OR) for ever smoking were 1.62 (95% confidence interval [CI]: 1.33-1.96) among male and 0.82 (95% CI: 0.53-1.26) among female. Age at first cigarette, duration of smoking and pack-years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg-negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03-1.52) for HBsAg-negative ever smokers, 7.66 (95% CI: 6.05-9.71) for HBsAg-positive never smokers, and 15.68 (95% CI: 12.06-20.39) for HBsAg-positive ever smokers. These different odds ratios indicated super-additive (RERI: 7.77, 95% CI: 3.81-11.73) and super-multiplicative interactions (ROR: 1.64, 95% CI: 1.17-2.30) between hepatitis B virus (HBV) infection and tobacco smoking. Most associations and interactions detected remained statistically significant after SB adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer.
Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population-based case-control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum hepatitis B surface antigen (HBsAg) and anti-HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semi-Bayes (SB) method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratios (OR) for ever smoking were 1.62 (95% confidence interval [CI]: 1.33-1.96) among male and 0.82 (95% CI: 0.53-1.26) among female. Age at first cigarette, duration of smoking and pack-years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg-negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03-1.52) for HBsAg-negative ever smokers, 7.66 (95% CI: 6.05-9.71) for HBsAg-positive never smokers, and 15.68 (95% CI: 12.06-20.39) for HBsAg-positive ever smokers. These different odds ratios indicated super-additive (RERI: 7.77, 95% CI: 3.81-11.73) and super-multiplicative interactions (ROR: 1.64, 95% CI: 1.17-2.30) between hepatitis B virus (HBV) infection and tobacco smoking. Most associations and interactions detected remained statistically significant after SB adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer.
Author Zhao, Jin‐Kou
Mu, Lina
He, Na
Li, Gang
Li, Liming
Han, Ren‐Qiang
Wang, Xu‐Shan
Baecker, Aileen
Liu, Xing
Zhou, Jin‐Yi
Gu, Xiaoping
Yang, Jie
Wang, Pei‐Hua
Jin, Zi‐Yi
Sun, Zheng
Wu, Ming
Liu, Ai‐Min
Zhang, Xiao‐Feng
Su, Ming
Hu, Xu
Zhang, Zuo‐Feng
AuthorAffiliation 1 Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA
8 Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY
3 Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China
2 Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China
4 Dafeng Center for Disease Control and Prevention, Dafeng, Jiangsu, China
7 Tongshan County Center for Disease control and Prevention, Tongshan, Jiangsu, China
5 Ganyu Center for Disease Control and Prevention, Ganyu, Jiangsu, China
6 Chuzhou County Center for Disease Control and Prevention, Chuzhou, Jiangsu, China
9 Department of Epidemiology, School of Public Health, Peking University, Beijing, China
AuthorAffiliation_xml – name: 3 Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China
– name: 8 Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY
– name: 4 Dafeng Center for Disease Control and Prevention, Dafeng, Jiangsu, China
– name: 9 Department of Epidemiology, School of Public Health, Peking University, Beijing, China
– name: 1 Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA
– name: 2 Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China
– name: 5 Ganyu Center for Disease Control and Prevention, Ganyu, Jiangsu, China
– name: 6 Chuzhou County Center for Disease Control and Prevention, Chuzhou, Jiangsu, China
– name: 7 Tongshan County Center for Disease control and Prevention, Tongshan, Jiangsu, China
Author_xml – sequence: 1
  givenname: Xing
  orcidid: 0000-0003-1385-9749
  surname: Liu
  fullname: Liu, Xing
  organization: School of Public Health, Fudan University
– sequence: 2
  givenname: Aileen
  surname: Baecker
  fullname: Baecker, Aileen
  organization: Fielding School of Public Health, University of California
– sequence: 3
  givenname: Ming
  surname: Wu
  fullname: Wu, Ming
  organization: Jiangsu Provincial Center for Disease Control and Prevention
– sequence: 4
  givenname: Jin‐Yi
  surname: Zhou
  fullname: Zhou, Jin‐Yi
  organization: Jiangsu Provincial Center for Disease Control and Prevention
– sequence: 5
  givenname: Jie
  surname: Yang
  fullname: Yang, Jie
  organization: Jiangsu Provincial Center for Disease Control and Prevention
– sequence: 6
  givenname: Ren‐Qiang
  surname: Han
  fullname: Han, Ren‐Qiang
  organization: Jiangsu Provincial Center for Disease Control and Prevention
– sequence: 7
  givenname: Pei‐Hua
  surname: Wang
  fullname: Wang, Pei‐Hua
  organization: Jiangsu Provincial Center for Disease Control and Prevention
– sequence: 8
  givenname: Zi‐Yi
  surname: Jin
  fullname: Jin, Zi‐Yi
  organization: School of Public Health, Fudan University
– sequence: 9
  givenname: Ai‐Min
  surname: Liu
  fullname: Liu, Ai‐Min
  organization: Dafeng Center for Disease Control and Prevention
– sequence: 10
  givenname: Xiaoping
  surname: Gu
  fullname: Gu, Xiaoping
  organization: Dafeng Center for Disease Control and Prevention
– sequence: 11
  givenname: Xiao‐Feng
  surname: Zhang
  fullname: Zhang, Xiao‐Feng
  organization: Ganyu Center for Disease Control and Prevention
– sequence: 12
  givenname: Xu‐Shan
  surname: Wang
  fullname: Wang, Xu‐Shan
  organization: Ganyu Center for Disease Control and Prevention
– sequence: 13
  givenname: Ming
  surname: Su
  fullname: Su, Ming
  organization: Chuzhou County Center for Disease Control and Prevention
– sequence: 14
  givenname: Xu
  surname: Hu
  fullname: Hu, Xu
  organization: Chuzhou County Center for Disease Control and Prevention
– sequence: 15
  givenname: Zheng
  surname: Sun
  fullname: Sun, Zheng
  organization: Tongshan County Center for Disease control and Prevention
– sequence: 16
  givenname: Gang
  surname: Li
  fullname: Li, Gang
  organization: Tongshan County Center for Disease control and Prevention
– sequence: 17
  givenname: Lina
  surname: Mu
  fullname: Mu, Lina
  organization: University at Buffalo, The State University of New York
– sequence: 18
  givenname: Na
  surname: He
  fullname: He, Na
  organization: School of Public Health, Fudan University
– sequence: 19
  givenname: Liming
  surname: Li
  fullname: Li, Liming
  organization: School of Public Health, Peking University
– sequence: 20
  givenname: Jin‐Kou
  surname: Zhao
  fullname: Zhao, Jin‐Kou
  organization: Jiangsu Provincial Center for Disease Control and Prevention
– sequence: 21
  givenname: Zuo‐Feng
  orcidid: 0000-0002-4669-3995
  surname: Zhang
  fullname: Zhang, Zuo‐Feng
  email: zfzhang@ucla.edu
  organization: Fielding School of Public Health, University of California
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29193051$$D View this record in MEDLINE/PubMed
BookMark eNpdkU9rGzEQxUVJaRy3h36BIuill0000v7TpdCaJnUJ9JKchVaejeWspa2ktcm3rxynISkMzMD7zWOGd0ZOnHdIyEdg58AYv7Abcy4AWnhDZsBkUzAO1QmZZY0VDYj6lJzFuGEMoGLlO3LKJUjBKpiR_dIlDNok6x3tMO0RHU2-08Z4Grf-3ro7qt2KrnHUySYb6Xe6s2GK1Loej3u50hppsPGe-p4OdoeBGu1MbtZRTRdr6zAiHf04Dfqw85687fUQ8cNTn5Pbyx83i5_F9e-r5eLbdTGKWkLRlKLrmtWq1AC1aGVX9hqwLvMDZdVJ4LKpjWYaG4nAdddLfhB6bKqeV60Rc_L16DtO3RZXBl0KelBjsFsdHpTXVr1WnF2rO79TVQulEG02-PJkEPyfCWNSWxsNDoN26KeoQDZQV6zO9Jx8_g_d-Cm4_J7iOQrgrK4P1KeXFz2f8i-TDFwcgb0d8OFZB6YOYasctnoMWy1_LR4H8ReVSp7R
ContentType Journal Article
Copyright 2017 UICC
2017 UICC.
2018 UICC
Copyright_xml – notice: 2017 UICC
– notice: 2017 UICC.
– notice: 2018 UICC
DBID CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
5PM
DOI 10.1002/ijc.31181
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 1567
ExternalDocumentID PMC5814338
29193051
IJC31181
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center
– fundername: National Institutes of Health
– fundername: Department of Health and Human Services
  funderid: ES06718 ; ES011667 ; CA90833; CA077954; CA96134; DA11386; CA09142
– fundername: National Institute of Environmental Health Sciences
– fundername: Jiangsu Provincial Health Department
  funderid: RC 2003090
– fundername: National Cancer Institute
– fundername: NCI NIH HHS
  grantid: T32 CA009142
– fundername: NIDA NIH HHS
  grantid: R01 DA011386
– fundername: FIC NIH HHS
  grantid: D43 TW000013
– fundername: NCI NIH HHS
  grantid: R01 CA090833
– fundername: NCI NIH HHS
  grantid: U01 CA096134
– fundername: NCI NIH HHS
  grantid: R03 CA077954
– fundername: NIEHS NIH HHS
  grantid: R21 ES011667
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAMMB
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-p3691-743bb7dd4a116389b4fa1e6429145b912976ca0ae79e12abf92145bfe75f258c3
IEDL.DBID DR2
ISSN 0020-7136
1097-0215
IngestDate Thu Aug 21 14:07:40 EDT 2025
Fri Jul 11 02:58:38 EDT 2025
Fri Jul 25 09:23:53 EDT 2025
Mon Jul 21 05:41:56 EDT 2025
Wed Jan 22 16:29:03 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Chinese population
interaction
tobacco smoking
liver cancer
population attributable risk
Language English
License 2017 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p3691-743bb7dd4a116389b4fa1e6429145b912976ca0ae79e12abf92145bfe75f258c3
Notes The authors declare no potential conflicts of interest.
J.‐K.Z. and Z.‐F.Z. are cosenior authors
Conflict of interest
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Co-Senior Authors
ORCID 0000-0002-4669-3995
0000-0003-1385-9749
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.31181
PMID 29193051
PQID 2002120664
PQPubID 105430
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5814338
proquest_miscellaneous_1971650614
proquest_journals_2002120664
pubmed_primary_29193051
wiley_primary_10_1002_ijc_31181_IJC31181
PublicationCentury 2000
PublicationDate 15 April 2018
PublicationDateYYYYMMDD 2018-04-15
PublicationDate_xml – month: 04
  year: 2018
  text: 15 April 2018
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 1997; 278
2012
2017; 26
2010; 19
1995; 38
2010
2002; 11
2003; 14
2005; 20
2004; 5
1988; 79
2004
1987; 39
2005; 45
2007; 36
1994; 43
1985; 69
2004; 96
1990; 87
2004; 51
2011; 106
2017; 39
2004; 39
2017; 10
1982; 42
1993; 53
1984; 34
1992; 339
2015
1996; 275
1999; 30
2001; 39
2013
1998; 7
2009; 38
2011; 364
References_xml – volume: 38
  start-page: 1497
  year: 2009
  end-page: 511
  article-title: Meta‐analysis of epidemiologic studies on cigarette smoking and liver cancer
  publication-title: Int J Epidemiol
– volume: 79
  start-page: 1075
  year: 1988
  end-page: 82
  article-title: Blood transfusion, alcohol consumption, and cigarette smoking in causation of hepatocellular carcinoma: a case–control study in Fukuoka, Japan
  publication-title: Jpn J Cancer Res Gann
– volume: 7
  start-page: 141
  year: 1998
  end-page: 8
  article-title: Mortality attributable to cigarette smoking in Taiwan: a 12‐year follow‐up study
  publication-title: Tob Control
– volume: 19
  start-page: 1261
  year: 2010
  end-page: 8
  article-title: Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta‐analysis
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 42
  start-page: 5246
  year: 1982
  end-page: 8
  article-title: Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong
  publication-title: Cancer Res
– volume: 38
  start-page: 155
  year: 1995
  end-page: 61
  article-title: Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China
  publication-title: Intervirology
– volume: 39
  start-page: 109
  year: 2001
  end-page: 18
  article-title: Hepatocellular carcinoma: an overview
  publication-title: Histopathology
– volume: 96
  start-page: 1851
  year: 2004
  end-page: 6
  article-title: Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea
  publication-title: J Natl Cancer Inst
– volume: 364
  start-page: 2469
  year: 2011
  end-page: 70
  article-title: Prevalence of smoking in China in 2010
  publication-title: N Engl J Med
– volume: 51
  start-page: 71
  year: 2004
  end-page: 81
  article-title: Risk of death due to hepatocellular carcinoma among smokers and ex‐smokers. Univariate analysis of JACC study data
  publication-title: Kurume Med J
– volume: 87
  start-page: 19
  year: 1990
  end-page: 26
  article-title: Cigarette smoking and cancer mortality risk in Japanese men and women—results from reanalysis of the six‐prefecture cohort study data
  publication-title: Environ Health Perspect
– volume: 5
  start-page: 363
  year: 2004
  end-page: 73
  article-title: Cigarette smoking, metabolic activation and carcinogenesis
  publication-title: Curr Drug Metab
– volume: 278
  start-page: 1500
  year: 1997
  end-page: 4
  article-title: Early health effects of the emerging tobacco epidemic in China. A 16‐year prospective study
  publication-title: JAMA
– volume: 69
  start-page: 213
  year: 1985
  end-page: 5
  article-title: Hepatitis B virus and primary liver cancer on Chongming Island, People's Republic of China
  publication-title: Natl Cancer Inst Monogr
– volume: 43
  start-page: 276
  year: 1994
  end-page: 80
  article-title: A nested case–control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan
  publication-title: J Med Virol
– volume: 30
  start-page: 379
  year: 1999
  end-page: 83
  article-title: Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1
  publication-title: Hepatology
– year: 2010
– year: 2012
– volume: 39
  start-page: 45
  year: 1987
  end-page: 9
  article-title: Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma
  publication-title: Int J Cancer
– volume: 106
  start-page: 1946
  year: 2011
  end-page: 56
  article-title: Drinking behaviour among men and women in China: the 2007 China chronic disease and risk factor surveillance
  publication-title: Addict Abingdon Engl
– volume: 20
  start-page: 575
  year: 2005
  end-page: 9
  article-title: Calculating measures of biological interaction
  publication-title: Eur J Epidemiol
– volume: 339
  start-page: 943
  year: 1992
  end-page: 6
  article-title: Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
  publication-title: Lancet Lond Engl
– volume: 39
  start-page: 14
  year: 2017
  article-title: Modulation of benzo[ ]pyrene–DNA adduct formation by CYP1 inducer and inhibitor
  publication-title: Genes Environ
– volume: 26
  start-page: 357
  year: 2017
  end-page: 64
  article-title: Jiangsu Four Cancers Study: a large case–control study of lung, liver, stomach, and esophageal cancers in Jiangsu Province, China
  publication-title: Eur J Cancer Prev
– volume: 53
  start-page: 790
  year: 1993
  end-page: 4
  article-title: Elevated serum testosterone levels and risk of hepatocellular carcinoma
  publication-title: Cancer Res
– volume: 14
  start-page: 241
  year: 2003
  end-page: 50
  article-title: Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg‐seropositive and 9421 HBsAg‐seronegative male residents in Taiwan
  publication-title: Cancer Causes Control
– volume: 45
  start-page: 106
  year: 2005
  end-page: 14
  article-title: Carcinogenic polycyclic aromatic hydrocarbon‐DNA adducts and mechanism of action
  publication-title: Environ Mol Mutagen
– year: 2004
– volume: 39
  start-page: 528
  year: 2004
  end-page: 35
  article-title: The mortality risks of smokers in Taiwan: Part I: cause‐specific mortality
  publication-title: Prev Med
– volume: 10
  start-page: 245
  year: 2017
  end-page: 54
  article-title: Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies
  publication-title: J Evid Based Med
– volume: 275
  start-page: 1646
  year: 1996
  end-page: 50
  article-title: Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study
  publication-title: JAMA
– volume: 11
  start-page: 369
  year: 2002
  end-page: 76
  article-title: Eight‐year follow‐up of the 90,000‐person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences
  publication-title: Cancer Epidemiol Biomark Prev
– volume: 36
  start-page: 195
  year: 2007
  end-page: 202
  article-title: Bayesian perspectives for epidemiological research. II. Regression analysis
  publication-title: Int J Epidemiol
– year: 2015
– volume: 34
  start-page: 775
  year: 1984
  end-page: 9
  article-title: Follow‐up study of HBs Ag‐positive blood donors with special reference to effect of drinking and smoking on development of liver cancer
  publication-title: Int J Cancer
– year: 2013
SSID ssj0011504
Score 2.4297347
Snippet Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and...
SourceID pubmedcentral
proquest
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1560
SubjectTerms Asian People
Bayes Theorem
Bayesian analysis
Cancer
Case-Control Studies
Chinese population
Epidemiology
Female
Health risk assessment
Hepatitis
Hepatitis B
Hepatitis B - blood
Hepatitis B - complications
Hepatitis B surface antigen
Hepatitis B Surface Antigens - blood
Hepatitis B virus - pathogenicity
Humans
Infections
interaction
Liver cancer
Liver Neoplasms - blood
Liver Neoplasms - etiology
Liver Neoplasms - virology
Male
Medical research
Middle Aged
Odds Ratio
population attributable risk
Population studies
Risk Factors
Smoking
Smoking - adverse effects
Statistical analysis
Tobacco
Tobacco smoking
Tobacco Smoking - adverse effects
Title Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.31181
https://www.ncbi.nlm.nih.gov/pubmed/29193051
https://www.proquest.com/docview/2002120664
https://www.proquest.com/docview/1971650614
https://pubmed.ncbi.nlm.nih.gov/PMC5814338
Volume 142
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Ni9UwEB-WPYgXvz-qq4zgwUt3m7ykbfCki8u6sB7EhT0IJUlT9q3aPl7fU_Cvdyb90FUPIvRQSAIpk5n-JvnNLwDPjQ4qqEamWajzVDlKWMuF9anLCC3bWugm1q2dvsuPz9TJuT7fgZdTLcygDzFvuLFnxHjNDm5df_BTNHR56SnhFLHsmrlaDIjez9JRDHRGBeYspUQsn1SFMnkwj_wbqvyTHPkraI1_naOb8HGa70A2-bS_3bh9__03Kcf__KBbcGNEo_hqWD63YSe0d-Da6Xjefhe-xQ3DofYBR0oXcgjwvsP-S8f77GjbGi8CM7M3yx5f49fletvjxPJqkR5Cmcgkduwa_MxMEPS82tbUCy3yHd6hD7iaLxO7B2dHbz4cHqfjVQ3papEbkRIOca6oa2UFAzzjVGNFoNzGCKWdIVBR5N5mNhQmCGldY1gh3TWh0I3UpV_ch922a8NDQIp4WsumdM4ZJQiBcBJHuEhaWfta6gT2JqNVo7_1VaSasDK9SuDZ3Eyewscftg3dtq8Eq2VpzoATeDDYuFoNkh4VzdNQ5BMJFFesP3dgFe6rLe3yIqpx65Ig56JM4EU07jxi0IOWFZm1imat3p4cxpdH_971MVwnhFby8ZXQe7C7WW_DE0JBG_c0LvcftacEJw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIuUN6BAkbiwCVt7LWTWOJSKqpt6faAWqkXZNmJoy6PZLXZbSV-PTPOAwocEFIOkWxLjsYz-WY88w3Aa6289LISceLLNJYOHdZ8YovYJYiWbclVFerWZifp9EwenavzDXg71MJ0_BBjwI00I9hrUnAKSO_-ZA2dfy7Q4-RUd32DOnoHh-rjSB5FUKfnYE5idMXSgVcoEbvj0r_hyj_TI3-FreG_c3AXPg077tJNvuysV26n-P4bmeP_ftIW3OkBKdvrTtA92PD1fbg566_cH8BViBl25Q-sz-piZAWKomHtt4ZC7czWJbvwlJy9mrfsHbucL9ctGxK9aoYPAk1GeeysqdhXSgZhBR24Jc5illEbb996thj7iT2Es4P3p_vTuO_WEC8mqeYxQhHnsrKUlhPG005Wlnt0bzSXymnEFVla2MT6THsurKs0kaS7ymeqEiovJo9gs25q_wQYGj2lRJU757TkCELIj0NoJKwoi1KoCLYHqZle5VoTsk2InF5G8GocRmWhGxBb-2bdGk6EWYqc4Aged0I2i47Vw-A-NRo_HkF2TfzjBCLivj5Szy8CIbfKEXVO8gjeBOmOKzpKaGFQrCaI1Rwe7YeXp_8-9SXcmp7Ojs3x4cmHZ3AbAVtOt1lcbcPmarn2zxEUrdyLcPZ_AOUICEI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ba9UwGP8YE4YvOq-rmxrBB1-6NTlJ2-DTLh626YaIgz0IIWlTdry0h9NzFPzr_b70olMfROhDIQmkfJf-vuSXXwCea-Wll5WIE1-msXRYsOYTW8QuQbRsS66qcG7t7Dw9vpCnl-pyDV4OZ2E6fYhxwY0iI-RrCvB5We39FA2dfSyw4OR07PqGTJOcXPro3agdRUinl2BOYqzE0kFWKBF749C_wco_2ZG_otbw25nehg_DhDu2yafd1dLtFt9_03L8zy_ahFs9HGX7nf_cgTVf34WNs37D_R58CyuG3eEH1nO6GOWAomhY-6WhhXZm65JdeaJmL2ctO2BfZ4tVywaaV83wQZjJiMXOmop9JioIK8jdFtiLWUaXePvWs_l4m9h9uJi-en94HPd3NcTzSap5jEDEuawspeWE8LSTleUeixvNpXIaUUWWFjaxPtOeC-sqTRLprvKZqoTKi8kDWK-b2m8Bw5SnlKhy55yWHCEIVXEIjIQVZVEKFcHOYDTTB1xrAteEpOllBM_GZgwV2v-wtW9WreEkl6WoBI7gYWdjM-80PQzOU2Pq4xFk16w_diAZ7ust9ewqyHGrHDHnJI_gRTDuOKIThBYGzWqCWc3J6WF4efTvXZ_CxtujqXlzcv56G24iWstpK4urHVhfLlb-MSKipXsSPP8H6nIG-g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interaction+between+tobacco+smoking+and+hepatitis+B+virus+infection+on+the+risk+of+liver+cancer+in+a+Chinese+population&rft.jtitle=International+journal+of+cancer&rft.au=Liu%2C+Xing&rft.au=Baecker%2C+Aileen&rft.au=Wu%2C+Ming&rft.au=Zhou%2C+Jin-Yi&rft.date=2018-04-15&rft.eissn=1097-0215&rft.volume=142&rft.issue=8&rft.spage=1560&rft_id=info:doi/10.1002%2Fijc.31181&rft_id=info%3Apmid%2F29193051&rft.externalDocID=29193051
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon